NASDAQ · Medical - Devices

TMDX (TMDX) Stock

$78.00 +2.24% NASDAQ: TMDX Healthcare

Valuation

MetricValue
Price$78.00
Market Cap$2.70B
P/E Ratio14.63
P/B Ratio4.63
P/S Ratio3.47
EPS (TTM)$4.87
52-Week High$156.00
52-Week Low$60.10
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE45.22%
ROA5.20%
ROCE23.04%
Gross Margin59.09%
Operating Margin14.85%
Net Margin27.04%
Debt/Equity1.66
Current Ratio7.17

Annual Financials (USD)

Metric20212022202320242025
Revenue$30.0M$93.0M$242.0M$442.0M$605.0M
Operating Profit$-39.0M$-31.0M$-29.0M$37.0M$109.0M
Net Profit$-44.0M$-36.0M$-25.0M$35.0M$190.0M
EPS$-1.60$-1.23$-0.77$1.01$4.87
Op Margin-130.3%-33.6%-11.9%8.5%17.9%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$135.0M$277.0M$706.0M$804.0M$1.1B
Total Liabilities$67.0M$90.0M$569.0M$575.0M$595.0M
Cash$26.0M$201.0M$395.0M$337.0M$488.0M
Borrowings$44.0M$68.0M$516.0M$518.0M$470.0M

Latest News

TMDX: Raising target price to $71.00 Argus Research · Jul 15, 2026 Is TransMedics Group, Inc. (TMDX) Stock Still a MedTech Growth Opportunity After Analyst Target Cut? Insider Monkey · Jul 8, 2026 TransMedics Group Announces Completion of Strategic Investment in PAD Aviation service GmbH PR Newswire · Jul 6, 2026 Where Will TransMedics Group Stock Be in 10 Years? Motley Fool · Jul 3, 2026 3 Growth Stocks to Buy on the Dip Motley Fool · Jul 2, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-29.0M$-46.0M$-13.0M$49.0M$193.0M
Investing Cash Flow$26.0M$43.0M$-373.0M$-259.0M$-119.0M
Financing Cash Flow$1.0M$6.0M$-45.0M$0$17.0M
Net Cash Flow$1.0M$176.0M$194.0M$-58.0M$152.0M
Free Cash Flow$-32.0M$-58.0M$-192.0M$-81.0M$134.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.07
EV / EBITDA20.83
FCF Yield6.85%
Quick Ratio6.19
Interest Coverage7.79
Return 1Y-32.58%
Return 3Y-21.42%
Return 5Y140.54%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AKROAkero Therapeutics, Inc. $54.65 +0.00% -19.87 $4.50B 0.00%
BRKR $62.91 +4.76% 23.24 $9.58B 0.35%
GKOS $166.72 -1.07% -42.65 $9.83B 0.00%
HNGE $75.11 +1.08% -13.65 $5.81B 0.00%
IMVT $39.24 +1.91% -11.09 $8.06B 0.00%

About TMDX

TMDX stock trades at $78.00 with a market capitalization of $2.70B. The stock is valued at a price-to-earnings (P/E) ratio of 14.63, price-to-book of 4.63, price-to-sales of 3.47. Over the past 52 weeks the stock has ranged between $60.10 and $156.00, and currently trades 50.0% below its 52-week high.

On profitability, TMDX generates a return on equity (ROE) of 45.22% — well above the market average, a sign of a high-quality business, return on capital employed of 23.04%, an operating margin of 14.85%, a net profit margin of 27.04%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides